RxDoctor Payments Data

David Tran, DPM

Podiatrist · Monroe, LANPI 1093247892

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (52.0%), education and consulting fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Integra Lifesciences Corporation at 42.3% of the total. Reporting peaked in 2024 at $10,675 and has fallen 84.7% since, to $1,632 in 2025. Among podiatrist clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,392in general payments, 2019–2025

Across 141 payments — averaging $172.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$10K
  • Stryker$5K
  • Arthrex$4K
  • Orthofix Medical, Inc.$2K
  • Midsouth Orthopedics Inc.$1K
  • CDC Medical LLC$843
  • plus $1K from 12 others

What the payments were for

  • Consulting fees$4,05017%
  • Travel & lodging$12,53552%
  • Food & beverage$3,29414%
  • Education$4,21818%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,392 in reported general payments places this provider in the 95th percentile of 68 podiatrist providers in Louisiana.

See all podiatrist providers in Louisiana

Medicare billing

Part B allowed, 2024
$186,873
Medicare patients
385
Services billed
1,266

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin21$420
Ketoconazole16$303
Ammonium Lactate12$154
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$117
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$69
Meloxicam18$28

Paid to pharmacies, not to this prescriber.

Other podiatrist in Monroe

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →